Atlas Trials

DEP Combine With PD-1 Antibody as an Treatment for EBV-HLH

Clinical trial NCT05164978 · UNKNOWN

Trial details

NCT number
NCT05164978
Sponsor
Beijing Friendship Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hemophagocytic Lymphohistiocytosis
Start date
2021-05-01
Primary completion
2023-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.